Report cover image

Global Marek's Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20356493

Description

Summary

According to APO Research, The global Marek's Disease Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Marek's Disease Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Marek's Disease Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Marek's Disease Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Marek's Disease Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Marek's Disease Vaccine include Boehringer Ingelheim, Ceva, Merial, Zoetis, Beijing Huadu Shihua Biological Products Co., Ltd., Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Guangxi Lichengdong Biological Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Marek's Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Marek's Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Marek's Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Marek's Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Marek's Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Marek's Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.

Marek's Disease Vaccine Segment by Company

Boehringer Ingelheim
Ceva
Merial
Zoetis
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Merck
Ruipu Biopharmaceutical Co., Ltd.
Marek's Disease Vaccine Segment by Type

Bivalent Vaccine
Monovalent Vaccine
Marek's Disease Vaccine Segment by Application

Veterinary Pharmacy
Online Sale
Others
Marek's Disease Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marek's Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marek's Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marek's Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Marek's Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Marek's Disease Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Marek's Disease Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Marek's Disease Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Marek's Disease Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Marek's Disease Vaccine Market Dynamics
2.1 Marek's Disease Vaccine Industry Trends
2.2 Marek's Disease Vaccine Industry Drivers
2.3 Marek's Disease Vaccine Industry Opportunities and Challenges
2.4 Marek's Disease Vaccine Industry Restraints
3 Marek's Disease Vaccine Market by Manufacturers
3.1 Global Marek's Disease Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Marek's Disease Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Marek's Disease Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Marek's Disease Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Marek's Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Marek's Disease Vaccine Manufacturers, Product Type & Application
3.7 Global Marek's Disease Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Marek's Disease Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Marek's Disease Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Marek's Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Marek's Disease Vaccine Market by Type
4.1 Marek's Disease Vaccine Type Introduction
4.1.1 Bivalent Vaccine
4.1.2 Monovalent Vaccine
4.2 Global Marek's Disease Vaccine Sales by Type
4.2.1 Global Marek's Disease Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Marek's Disease Vaccine Sales by Type (2020-2031)
4.2.3 Global Marek's Disease Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Marek's Disease Vaccine Revenue by Type
4.3.1 Global Marek's Disease Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Marek's Disease Vaccine Revenue by Type (2020-2031)
4.3.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2020-2031)
5 Marek's Disease Vaccine Market by Application
5.1 Marek's Disease Vaccine Application Introduction
5.1.1 Veterinary Pharmacy
5.1.2 Online Sale
5.1.3 Others
5.2 Global Marek's Disease Vaccine Sales by Application
5.2.1 Global Marek's Disease Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Marek's Disease Vaccine Sales by Application (2020-2031)
5.2.3 Global Marek's Disease Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Marek's Disease Vaccine Revenue by Application
5.3.1 Global Marek's Disease Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Marek's Disease Vaccine Revenue by Application (2020-2031)
5.3.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2020-2031)
6 Global Marek's Disease Vaccine Sales by Region
6.1 Global Marek's Disease Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Marek's Disease Vaccine Sales by Region (2020-2031)
6.2.1 Global Marek's Disease Vaccine Sales by Region (2020-2025)
6.2.2 Global Marek's Disease Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Marek's Disease Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Marek's Disease Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Marek's Disease Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Marek's Disease Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Marek's Disease Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Marek's Disease Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Marek's Disease Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Marek's Disease Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Marek's Disease Vaccine Revenue by Region
7.1 Global Marek's Disease Vaccine Revenue by Region
7.1.1 Global Marek's Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Marek's Disease Vaccine Revenue by Region (2020-2025)
7.1.3 Global Marek's Disease Vaccine Revenue by Region (2026-2031)
7.1.4 Global Marek's Disease Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Marek's Disease Vaccine Revenue (2020-2031)
7.2.2 North America Marek's Disease Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Marek's Disease Vaccine Revenue (2020-2031)
7.3.2 Europe Marek's Disease Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Marek's Disease Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Marek's Disease Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Marek's Disease Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Marek's Disease Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Comapny Information
8.1.2 Boehringer Ingelheim Business Overview
8.1.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
8.1.5 Boehringer Ingelheim Recent Developments
8.2 Ceva
8.2.1 Ceva Comapny Information
8.2.2 Ceva Business Overview
8.2.3 Ceva Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Ceva Marek's Disease Vaccine Product Portfolio
8.2.5 Ceva Recent Developments
8.3 Merial
8.3.1 Merial Comapny Information
8.3.2 Merial Business Overview
8.3.3 Merial Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merial Marek's Disease Vaccine Product Portfolio
8.3.5 Merial Recent Developments
8.4 Zoetis
8.4.1 Zoetis Comapny Information
8.4.2 Zoetis Business Overview
8.4.3 Zoetis Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Zoetis Marek's Disease Vaccine Product Portfolio
8.4.5 Zoetis Recent Developments
8.5 Beijing Huadu Shihua Biological Products Co., Ltd.
8.5.1 Beijing Huadu Shihua Biological Products Co., Ltd. Comapny Information
8.5.2 Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview
8.5.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
8.5.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
8.6 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
8.6.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Comapny Information
8.6.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview
8.6.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
8.6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
8.7 Guangxi Lichengdong Biological Co., Ltd.
8.7.1 Guangxi Lichengdong Biological Co., Ltd. Comapny Information
8.7.2 Guangxi Lichengdong Biological Co., Ltd. Business Overview
8.7.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
8.7.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
8.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
8.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Comapny Information
8.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
8.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
8.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
8.9 Merck
8.9.1 Merck Comapny Information
8.9.2 Merck Business Overview
8.9.3 Merck Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Merck Marek's Disease Vaccine Product Portfolio
8.9.5 Merck Recent Developments
8.10 Ruipu Biopharmaceutical Co., Ltd.
8.10.1 Ruipu Biopharmaceutical Co., Ltd. Comapny Information
8.10.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
8.10.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
8.10.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Marek's Disease Vaccine Value Chain Analysis
9.1.1 Marek's Disease Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Marek's Disease Vaccine Production Mode & Process
9.2 Marek's Disease Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Marek's Disease Vaccine Distributors
9.2.3 Marek's Disease Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.